ATE397454T1 - High density lipoprotein zur bekämpfung von organdysfunktion infolge eines hämorrhagischen schocks - Google Patents

High density lipoprotein zur bekämpfung von organdysfunktion infolge eines hämorrhagischen schocks

Info

Publication number
ATE397454T1
ATE397454T1 AT03076918T AT03076918T ATE397454T1 AT E397454 T1 ATE397454 T1 AT E397454T1 AT 03076918 T AT03076918 T AT 03076918T AT 03076918 T AT03076918 T AT 03076918T AT E397454 T1 ATE397454 T1 AT E397454T1
Authority
AT
Austria
Prior art keywords
high density
density lipoprotein
combat
result
hemorrhagic shock
Prior art date
Application number
AT03076918T
Other languages
English (en)
Inventor
Gillian Cockerill
Norman Miller
Christoph Thiemermann
Michelle Macdonald
Original Assignee
Csl Behring Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Behring Ag filed Critical Csl Behring Ag
Application granted granted Critical
Publication of ATE397454T1 publication Critical patent/ATE397454T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT03076918T 1999-08-19 2000-08-16 High density lipoprotein zur bekämpfung von organdysfunktion infolge eines hämorrhagischen schocks ATE397454T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9919713.9A GB9919713D0 (en) 1999-08-19 1999-08-19 New medical use of high density lipoprotein

Publications (1)

Publication Number Publication Date
ATE397454T1 true ATE397454T1 (de) 2008-06-15

Family

ID=10859485

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03076918T ATE397454T1 (de) 1999-08-19 2000-08-16 High density lipoprotein zur bekämpfung von organdysfunktion infolge eines hämorrhagischen schocks
AT00956651T ATE253931T1 (de) 1999-08-19 2000-08-16 High density lipoprotein zur bekämpfung von organdysfunktion infolge hämorrhagischem schocks

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT00956651T ATE253931T1 (de) 1999-08-19 2000-08-16 High density lipoprotein zur bekämpfung von organdysfunktion infolge hämorrhagischem schocks

Country Status (10)

Country Link
US (1) US6998388B1 (de)
EP (2) EP1369124B1 (de)
AT (2) ATE397454T1 (de)
AU (1) AU779578B2 (de)
CA (1) CA2376260C (de)
DE (2) DE60006548T2 (de)
DK (1) DK1210105T3 (de)
ES (2) ES2209961T3 (de)
GB (1) GB9919713D0 (de)
WO (1) WO2001013939A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035352A1 (de) * 2000-07-20 2002-01-31 Zlb Bioplasma Ag Bern Verfahren zur Behandlung von instabiler Angina pectoris
US20040266660A1 (en) 2001-08-20 2004-12-30 Alphonse Hubsch Hdl for the treatment of stroke and other ischemic conditions
EP1285662A1 (de) * 2001-08-20 2003-02-26 ZLB Bioplasma AG Rekonstituiertes High-Density -Lipoprotein zur Behandlung von Schlaganfällen und Ischämiezuständen
WO2005068020A1 (en) 2004-01-02 2005-07-28 Advanced Cardiovascular Systems, Inc. High-density lipoprotein coated medical devices
US7759315B2 (en) * 2005-03-09 2010-07-20 Csl Behring Ag Treatment of inflammatory conditions of the intestine
US8206750B2 (en) 2005-03-24 2012-06-26 Cerenis Therapeutics Holding S.A. Charged lipoprotein complexes and their uses
US7956035B2 (en) 2007-03-01 2011-06-07 Csl Limited Treatment of endothelial dysfunction in diabetic patients
US8734853B2 (en) 2008-11-17 2014-05-27 University Of North Texas Health Science Center At Fort Worth HDL particles for delivery of nucleic acids
PL2767546T3 (pl) 2011-02-07 2019-04-30 Cerenis Therapeutics Holding Sa Kompleksy lipoproteinowe i ich wytwarzanie oraz ich zastosowania
US20150316566A1 (en) 2014-05-02 2015-11-05 Cerenis Therapeutics Holding Sa Hdl therapy markers
US20160346221A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08198406A (ja) 1995-01-20 1996-08-06 Hitachi Ltd 自動倉庫設備
AU6773596A (en) 1995-08-17 1997-03-12 Protein Design Labs, Inc. Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage
DE19547648A1 (de) 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
JPH1025248A (ja) * 1996-07-08 1998-01-27 Chemo Sero Therapeut Res Inst 抗血管リモデリング剤

Also Published As

Publication number Publication date
WO2001013939A1 (en) 2001-03-01
DE60039130D1 (de) 2008-07-17
EP1369124A1 (de) 2003-12-10
ATE253931T1 (de) 2003-11-15
EP1210105B1 (de) 2003-11-12
ES2307869T3 (es) 2008-12-01
DK1210105T3 (da) 2004-03-22
GB9919713D0 (en) 1999-10-20
EP1369124B1 (de) 2008-06-04
DE60006548D1 (de) 2003-12-18
AU779578B2 (en) 2005-01-27
CA2376260A1 (en) 2001-03-01
AU6852500A (en) 2001-03-19
DE60006548T2 (de) 2004-09-23
ES2209961T3 (es) 2004-07-01
CA2376260C (en) 2010-09-28
EP1210105A1 (de) 2002-06-05
US6998388B1 (en) 2006-02-14

Similar Documents

Publication Publication Date Title
BR0313747A (pt) Inibidores de transcriptase reversa de não-nucleosìdeo
ATE397454T1 (de) High density lipoprotein zur bekämpfung von organdysfunktion infolge eines hämorrhagischen schocks
DE602004012745D1 (de) Synergistische zusammensetzung zur behandlung von diabetes mellitus
CO5700767A2 (es) Procedimiento de tratamiento de rechazo de transplantes
PT907652E (pt) Compostos e processos imunossupressores
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
DE60335244D1 (de) Behandlung von verletzungen des zentralen nervensystems
ATE509629T1 (de) Kombination von iap-inhibitoren und flt3- inhibitoren
MY148459A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
BRPI0410467A (pt) composições e métodos para tratamento de sìndrome respiratória aguda severa (sars)
ATE233483T1 (de) Wässrige lösung zum konservieren von gewebe und organen
ES2172171T3 (es) Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles.
IL147489A0 (en) Use of docetaxel for treating hepatocellular carcinoma
DE60124694D1 (de) Verbesserte lipidzusammensetzungen und darin enthaltene derivate des 3-methoxybenzylthioharnstoffs
ATE410154T1 (de) Pharmazeutische zusammensetzung enthaltend 2,4- dichlorbenzylalkohol und amylmetakresol
WO2003063782A3 (en) Kappa-pviia-related conotoxins as organ protectants
EP1539132A4 (de) Verwendung von 2,3 alkylcarbonyloxybenzosäuren, ihre derivate und analoga bei der behandlung von gewebe- und zellfunktionsschäden und verletzungen in säugetieren
DE60207442D1 (de) VERWENDUNG EINER KOMBINATIONSZUSAMMENSETZUNG BESTEHEND AUS PROPIONYL L-CARNITIN UND WEITEREn WIRKSTOFFEn ZUR BEHANDLUNG DER EREKTILEN DYSFUNKTION
DE60109594D1 (de) R-eliprodil zur behandlung von glaucoma
ATE482804T1 (de) Vorrichtung zur zerkleinerung von holzstämmen
BG101325A (en) Use of muramyl peptide compounds
BRPI0413262A (pt) uso de pelo menos um composto, e, processo para o tratamento de fruta de caroço
RU2004115884A (ru) Способ лечения омфалита у телят
UA33477A (uk) Спосіб індикації динітроортокрезолу

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1369124

Country of ref document: EP